Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immunex' highly purified interleukin-2 receptor

Executive Summary

Biotech firm announced it received a patent for its highly purified interleukin-2 receptor. Immunex maintained the patent is the first to cover a process for producing the receptor in a highly purified state, free of other proteins. The company said it is developing the receptor as a potential treatment for autoimmune diseases, including rheumatoid arthritis.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS010338

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel